XM does not provide services to residents of the United States of America.

US lawmakers say Brazil low-carbon fuel program blocks US companies



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US lawmakers say Brazil low-carbon fuel program blocks US companies</title></head><body>

By Marcelo Teixeira

NEW YORK, June 1 (Reuters) -A group of U.S. congressmen have formally complained about what they call unfair ethanol trade practices by Brazil that includes a blockade of U.S. companies seeking to take part in the Brazilian low-carbon biofuel program RenovaBio.

The bipartisan group of 21 members of the U.S. Congress are asking Trade Representative (USTR) Katherine Tai to address the Brazilian tariffs on U.S. ethanol and the non-tariff barrier created by the biofuel program implemented in 2020.

RenovaBio is a carbon market that gives Brazilian biofuel producers an additional revenue source. Companies such as ethanol makers generate carbon credits, called CBios, from the lower emissions of biofuels when compared to oil-derived fuels such as gasoline.

Those carbon credits are sold to fuel distributors in Brazil who have targets to cut emissions, or in a secondary market at Brazil's B3 exchange.

The lawmakers in a letter to the USTR complained about the implementation in Brazil in February of an import tariff of 16% on U.S. ethanol. That import tax will increase to 18% in 2024.

They also complained about the lack of approval from Brazilian authorities of U.S. companies' applications to take part in RenovaBio to be able to generate and sell carbon credits.

"Brazilian ethanol producers have access to our Renewable Fuel Standard and California's Low Carbon Fuel Standard program, which recognize the inherent value of low-carbon biofuels," the letter said. "This treatment is not reciprocated by Brazil, where U.S. ethanol producers, after two years, have yet to be approved for Brazil's biofuel program."

The U.S. government has said in the past that it was working with Brazilian officials to get certificates for U.S. ethanol plants.

Brazil's oil and biofuels regulator ANP, who is in charge of RenovaBio certification, did not immediately answer a request for comment.



Reporting by Marcelo Teixeira; Editing by Mark Porter

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.